As of 2026-02-16, the Relative Valuation of ACADIA Pharmaceuticals Inc (ACAD) is 27.26 USD. This relative valuation is based on P/E multiples. With the latest stock price at 22.47 USD, the upside of ACADIA Pharmaceuticals Inc based on Relative Valuation is 21.3%.
The range of the Relative Valuation is 24.05 - 31.06 USD.
| Range | Selected | |
| Trailing P/E multiples | 16.5x - 18.3x | 17.6x |
| Forward P/E multiples | 16.1x - 20.8x | 18.4x |
| Fair Price | 24.05 - 31.06 | 27.26 |
| Upside | 7.1% - 38.2% | 21.3% |
| Date | P/E |
| 2026-02-11 | 14.56 |
| 2026-02-10 | 14.70 |
| 2026-02-09 | 15.04 |
| 2026-02-06 | 15.26 |
| 2026-02-05 | 15.20 |
| 2026-02-04 | 15.70 |
| 2026-02-03 | 16.04 |
| 2026-02-02 | 16.93 |
| 2026-01-30 | 16.28 |
| 2026-01-29 | 16.65 |
| 2026-01-28 | 16.60 |
| 2026-01-27 | 16.97 |
| 2026-01-26 | 17.40 |
| 2026-01-23 | 17.39 |
| 2026-01-22 | 17.82 |
| 2026-01-21 | 17.33 |
| 2026-01-20 | 17.03 |
| 2026-01-16 | 16.84 |
| 2026-01-15 | 17.19 |
| 2026-01-14 | 17.40 |
| 2026-01-13 | 17.14 |
| 2026-01-12 | 17.22 |
| 2026-01-09 | 17.35 |
| 2026-01-08 | 17.43 |
| 2026-01-07 | 17.76 |
| 2026-01-06 | 17.45 |
| 2026-01-05 | 16.94 |
| 2026-01-02 | 17.03 |
| 2025-12-31 | 17.30 |
| 2025-12-30 | 17.30 |
| 2025-12-29 | 17.66 |
| 2025-12-26 | 17.89 |
| 2025-12-24 | 18.05 |
| 2025-12-23 | 18.03 |
| 2025-12-22 | 18.18 |
| 2025-12-19 | 17.59 |
| 2025-12-18 | 17.23 |
| 2025-12-17 | 17.44 |
| 2025-12-16 | 17.36 |
| 2025-12-15 | 17.66 |
| 2025-12-12 | 17.59 |
| 2025-12-11 | 17.28 |
| 2025-12-10 | 17.37 |
| 2025-12-09 | 17.42 |
| 2025-12-08 | 17.33 |
| 2025-12-05 | 17.77 |
| 2025-12-04 | 17.20 |
| 2025-12-03 | 16.76 |
| 2025-12-02 | 16.47 |
| 2025-12-01 | 16.10 |